ASRT Lead Plaintiff Deadline Approaching: Assertio Holdings, Inc. Shareholders Should Contact Robbins LLP for Information About the Class Action Against ASRT
22 févr. 2024 12h53 HE
|
Robbins LLP
Robbins LLP is Investigating the Allegations Against Assertio Holdings, Inc.
AMPL Shareholder Alert: Contact Robbins LLP for Information About Your Rights and Remedies Against Amplitude, Inc. (AMPL)
20 févr. 2024 15h25 HE
|
Robbins LLP
Robbins LLP Filed a Class Action Against Amplitude, Inc. on Behalf of Shareholders
NYCB Class Action Alert: Robbins LLP Reminds Shareholders of Lead Plaintiff Deadline in Class Action Against New York Community Bancorp, Inc.
20 févr. 2024 15h20 HE
|
Robbins LLP
Robbins LLP is Investigating the Allegations Against New York Community Bancorp, Inc.
LUXH Class Action Alert: Robbins LLP Reminds Shareholders of Lead Plaintiff Deadline in the Class Action Against LuxUrban Hotels Inc.
20 févr. 2024 14h59 HE
|
Robbins LLP
Robbins LLP is Investigating the Allegations Against LuxUrban Hotels Inc.
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against InMode Ltd. (INMD)
15 févr. 2024 19h45 HE
|
Robbins LLP
Robbins LLP is Investigating the Allegations Against InMode Ltd.
IRTC Class Action Alert: Robbins LLP Reminds Stockholders of Lead Plaintiff Deadline in iRhythm Technologies, Inc. Class Action
14 févr. 2024 19h59 HE
|
Robbins LLP
Robbins LLP is Investigating the Allegations Against iRhythm Technologies, Inc.
Investor Notice: Robbins LLP Informs Investors of Class Action Filed Against Xponential Fitness, Inc. (XPOF)
12 févr. 2024 15h08 HE
|
Robbins LLP
Robbins LLP is Investigating the Allegations Against Xponential Fitness, Inc.
EVVTY Shareholders are Reminded to Contact Robbins LLP for Information About the Lead Plaintiff Deadline in the Evolution AB (publ) Class Action
12 févr. 2024 13h41 HE
|
Robbins LLP
Evolution AB (EVVTY) Misled Investors Regarding its Business Prospects
BIVI Shareholders Who Lost Money Should Contact Robbins LLP for Information about the BioVie Inc. Class Action
10 févr. 2024 00h51 HE
|
Robbins LLP
BioVie Inc. (BIVI) Allegedly Failed to Disclose Scientific Misconduct in Connection with its Clinical Trial
ALVR Shareholders Who Lost Money Should Contact Robbins LLP for Information About the AlloVir, Inc. Class Action
10 févr. 2024 00h49 HE
|
Robbins LLP
AlloVir, Inc. (ALVR) Allegedly Misled Investors Regarding Efficacy of its posoleucel Phase 3 Studies